A practical treatment for COVID-19 and the next pandemic.
作者信息
Bhattacharya Jahar, Booy Robert, Casadevall Arturo, Dela Cruz Charles, Fedson David S, Garcia Joe G N, Grohmann Gary, Hung Ivan F N, Jacobson Jeffrey R, Jennings Lance C, Kobzik Lester, Leligdowicz Aleksandra, Liao James K, Martin Jennifer H, Musher Daniel M, Serhan Charles N, Tashiro Masato
机构信息
Department of Physiology & Cellular Biophysics, Vagelos Columbia College of Physicians & Surgeons, New York, New York, USA.
Department of Child and Adolescent Health, University of Sydney Medical School, Camperdown, New South Wales, Australia.
出版信息
Pharmacol Res Perspect. 2022 Aug;10(4):e00988. doi: 10.1002/prp2.988.
Abstract
摘要
相似文献
1
A practical treatment for COVID-19 and the next pandemic.
Pharmacol Res Perspect. 2022 Aug;10(4):e00988. doi: 10.1002/prp2.988.
2
The outcomes of the postulated interaction between SARS-CoV-2 and the renin-angiotensin system on the clinician's attitudes toward hypertension treatment.
J Hum Hypertens. 2021 Oct;35(10):828-836. doi: 10.1038/s41371-020-00436-w. Epub 2020 Nov 9.
3
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs.
Hum Vaccin Immunother. 2021 Sep 2;17(9):2841-2850. doi: 10.1080/21645515.2021.1920271. Epub 2021 May 28.
4
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
Hypertension. 2020 Jul;76(1):51-58. doi: 10.1161/HYPERTENSIONAHA.120.15143. Epub 2020 Apr 29.
5
Keep taking your ACE inhibitors and ARBs during the COVID 19 pandemic.
J Travel Med. 2020 May 18;27(3). doi: 10.1093/jtm/taaa045.
6
[ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
G Ital Cardiol (Rome). 2020 May;21(5):321-327. doi: 10.1714/3343.33127.
7
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.
Hypertens Res. 2020 Jul;43(7):648-654. doi: 10.1038/s41440-020-0455-8. Epub 2020 Apr 27.
8
Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities.
Pharmacol Ther. 2020 Nov;215:107628. doi: 10.1016/j.pharmthera.2020.107628. Epub 2020 Jul 9.
9
Mortality in Patients with COVID-19 on Renin Angiotensin System Inhibitor Long-Term Treatment: An Observational Study Showing that Things Are Not Always as They Seem.
Adv Ther. 2021 May;38(5):2709-2716. doi: 10.1007/s12325-021-01704-y. Epub 2021 Apr 1.
10
Controversy regarding ACE inhibitors / ARBs in COVID-19.
Rev Esp Cardiol (Engl Ed). 2020 Jun;73(6):516. doi: 10.1016/j.rec.2020.04.004. Epub 2020 Apr 15.
引用本文的文献
1
The Effectiveness of the Third Dose of COVID-19 Vaccine: When Should It Be Performed?
Vaccines (Basel). 2024 Mar 16;12(3):315. doi: 10.3390/vaccines12030315.
2
Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases.
Front Microbiol. 2024 Jan 5;14:1296447. doi: 10.3389/fmicb.2023.1296447. eCollection 2023.
3
Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients.
PLoS Comput Biol. 2023 May 5;19(5):e1011050. doi: 10.1371/journal.pcbi.1011050. eCollection 2023 May.
4
Treating COVID-19: Targeting the Host Response, Not the Virus.
Life (Basel). 2023 Mar 6;13(3):712. doi: 10.3390/life13030712.
5
Clinical and Prognostic Significance of Baseline Serum Vitamin D Levels in Hospitalized Egyptian Covid-19 Patients.
Int J Gen Med. 2022 Nov 7;15:8063-8070. doi: 10.2147/IJGM.S386815. eCollection 2022.
6
Perspectives of (/memorandum for) systems thinking on COVID-19 pandemic and pathology.
J Eval Clin Pract. 2023 Apr;29(3):415-429. doi: 10.1111/jep.13772. Epub 2022 Sep 28.
本文引用的文献
1
The pandemic's true death toll: millions more than official counts.
Nature. 2022 Jan;601(7893):312-315. doi: 10.1038/d41586-022-00104-8.
2
Beyond Omicron: what's next for COVID's viral evolution.
Nature. 2021 Dec;600(7888):204-207. doi: 10.1038/d41586-021-03619-8.
3
Dissecting the early COVID-19 cases in Wuhan.
Science. 2021 Dec 3;374(6572):1202-1204. doi: 10.1126/science.abm4454. Epub 2021 Nov 18.
4
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.
Lancet. 2021 Dec 4;398(10316):2093-2100. doi: 10.1016/S0140-6736(21)02249-2. Epub 2021 Oct 29.
5
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial.
Lancet Glob Health. 2022 Jan;10(1):e42-e51. doi: 10.1016/S2214-109X(21)00448-4. Epub 2021 Oct 28.
6
Statin withdrawal and treating COVID-19 patients.
Pharmacol Res Perspect. 2021 Dec;9(6):e00861. doi: 10.1002/prp2.861.
7
Efficacy of Statin Therapy in Patients with Hospital Admission for COVID-19.
Cardiovasc Drugs Ther. 2022 Dec;36(6):1165-1173. doi: 10.1007/s10557-021-07263-2. Epub 2021 Sep 15.
8
Statins use and COVID-19 outcomes in hospitalized patients.
PLoS One. 2021 Sep 10;16(9):e0256899. doi: 10.1371/journal.pone.0256899. eCollection 2021.
9
Innovative treatment as a precursor to clinical research.
J Clin Invest. 2021 Aug 2;131(15). doi: 10.1172/JCI152573.
10
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs.
Hum Vaccin Immunother. 2021 Sep 2;17(9):2841-2850. doi: 10.1080/21645515.2021.1920271. Epub 2021 May 28.
Zotero 插件